Abstract:their therapeutic potential in CLC has not been determined.Here, we identified that miR-410 is involved in CLC development through direct regulation of the X-linked inhibitor of apoptosis (XIAP).Methods: A microRNA library (810 microRNAs) was transfected in TFK CLC cells and cell viability was measured 48h later by a CellTiter-Glo assay.MicroRNA array analysis was performed in 22 human CLCs and 12 normal human cholangiocytes MiR-410 was overexpressed (20nM) in TFK cells and soft-agar colony and matrigel invasion assays were performed.MiR-410 was overexpressed in TFK CLC cells or suppressed (20nM) in H69 non-malignant cholangiocytes and their ability to form colonies in soft-agar was tested 20 days later.5x106 TFK cells were injected subcutaneously in nude mice and when tumors reached 100mm3 size, the mice were randomly distributed in groups: untreated, treated with miR-410 (2mg/kg), treated with sorafenib (20mg/kg), treated with miR-410 and sorafenib.All treatments were repeated for 4 cycles every 5 days and tumor size was measured in a daily basis.Results: The microRNA screen revealed that miR-410 suppressed effectively (72%) the growth of TFK cholangiocarcinoma cells.Furthermore, microRNA array analysis in 22 human cholangiocarcinomas and 12 normal human cholangiocytes revealed that miR-410 was highly (9.1-fold) down-regulated in CLCs relative to normal cholangiocytes.Overexpression of miR-410 suppressed (82%) the colony formation ability and invasiveness (6.6-fold) of TFK cells.On the other hand, inhibition of miR-410, by an antisense-microRNA against miR-410, transformed H69 non-malignant cholangiocytes.Bioinformatic analysis revealed that miR-410 has a binding site in the 3'UTR of XIAP gene.MiR-410 overexpression inhibited 72% XIAP luciferase activity and 7.1-fold XIAP mRNA levels in TFK cells.MiR-410 was found down-regulated and XIAP was found up-regulated in 12/22 (54.5%) human CLCs suggesting their human relevance.Overexpression of miR-410 suppressed 64% while sorafenib suppressed 38% the growth of TFK xenograft tumors in mice.Combinatorial treatment with miR-410 and sorafenib suppressed more effectively (88%) TFK tumor growth.Conclusion: We have identified that the miR-410/XIAP pathway is important for the transformation of human cholangiocytes and miR-410 treatment as a monotherapy or in combination with sorafenib suppresses CLC tumor growth in mice, suggesting its therapeutic potential for CLC patients.1050

<i>MicroRNA</i>-215 Regulates the Apoptosis of HCT116 Colon Cancer Cells by Inhibiting X-Linked Inhibitor of Apoptosis Protein

MiR-23a Modulates X-linked Inhibitor of Apoptosis-Mediated Autophagy in Human Luminal Breast Cancer Cell Lines.

MicroRNA-421 Inhibits Apoptosis by Downregulating Caspase-3 in Human Colorectal Cancer

MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells.

miR-181d Inhibits Proliferation and Promotes Apoptosis in Colon Cancer Cells

Inhibition of Microrna-383 Promotes Apoptosis of Human Colon Cancer Cells by Upregulation of Caspase-2 Gene Expression

Overexpression of Mir-215-3p Sensitizes Colorectal Cancer to 5-Fluorouracil Induced Apoptosis Through Regulating CXCR1.

Mir-497 Induces Hepatocellular Carcinoma Cell Lm3 Apoptosis Through Downregulating Xiap

MicroRNA-135b Regulates Apoptosis and Chemoresistance in Colorectal Cancer by Targeting Large Tumor Suppressor Kinase 2.

MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer by Downregulating BMI1 Polycomb Ring Finger Oncogene

Microrna-137 Promotes Apoptosis in Ovarian Cancer Cells Via the Regulation of Xiap

XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma

Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer.

microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2.

1052 MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer Cells by Downregulating Oncogene BMI1

microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells.

Microrna-195 Promotes Apoptosis and Suppresses Tumorigenicity of Human Colorectal Cancer Cells.

Mir-1915 Inhibits Bcl-2 to Modulate Multidrug Resistance by Increasing Drug-Sensitivity in Human Colorectal Carcinoma Cells.

Abstract 3966: Regulation of Chd5 Expression by Microrna-211 and Microrna-130B in Colorectal Cancer

MicroRNA-155 Regulates the Proliferation, Cell Cycle, Apoptosis and Migration of Colon Cancer Cells and Targets CBL.